19 October 2026
strategyland.uk
Currys PLC (CURY)
Rank #82 of 280 - Consumer Cyclicals - UK Equities
Currys PLC
Factor Analysis Summary
Editorial assessment generated from Currys PLC's live factor scores and sector positioning.
Based on Strategyland's proprietary 7-factor analysis, Currys PLC (CURY.L) currently holds an overall rank of #82 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.
Key strengths include asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively, and valuation (P/E 10.6, dividend yield 6.8%), where it demonstrates reasonable valuation with several price-based metrics ranking favourably.
Areas requiring attention include market trading, where low relative volume or adverse volatility patterns may deter momentum-oriented investors, as well as profitability (ROE 7.1%, net margin 1.8%), where compressed margins and weak returns on equity weigh on the earnings profile.
Within the Consumer Cyclicals sector, Currys PLC sits at composite rank #82, trailing the Consumer Cyclicals peer average (rank 44). It ranks behind all 6 tracked Consumer Cyclicals peers in our model.
The composite profile is weighed down by 5 below-average factor scores, with market trading (rank 255/280) representing the most significant drag on its #82 overall standing.
Strongest Factors
- Asset Efficiency — Rank 24/280 (top quartile)
- Valuation — Rank 89/280 (above average)
- Solvency — Rank 206/280 (below average)
Weakest Factors
- Market Trading — Rank 255/280 (below average)
- Profitability — Rank 246/280 (below average)
Score Analysis
Currys PLC is ranked #82 out of 280 UK stocks. Lower factor scores indicate better performance in that category.
Factor Breakdown
1. Liquidity
Score: 232/280How liquid is CURY and can it meet its short-term obligations?
Key Liquidity Metrics
Overall Liquidity Rank
2. Valuation
Score: 89/280Is CURY undervalued compared to its peers and fair value metrics?
Key Valuation Metrics
Dividend
CURY pays a dividend yield of 6.82%.
Dividend Per Share Forecast
3. Profitability
Score: 246/280How profitable is CURY relative to its peers?
EPS Growth
4. Solvency
Score: 206/280How strong is CURY's balance sheet and financial position?
Key Solvency Metrics
Altman Z-Score
5. Asset Efficiency
Score: 24/280How efficiently does CURY deploy its assets and intellectual capital?
Overall Asset Efficiency Rank
6. Market Trading
Score: 255/280How liquid and actively traded is CURY?
Trading Volume
7. Technical
Score: 226/280What do the technical indicators say about CURY?
RSI (14 Day)
Moving Averages
Risk Metrics
Peer Comparison
How does CURY compare to other Consumer Cyclicals stocks?
Overall Rank Comparison
Factor Score Comparison
Similar Stocks
Other top-ranked stocks in the Consumer Cyclicals sector
LiveCatch Healthcare Events Before the Market Moves
SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.
Methodology Note
The analysis presented for Currys PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.
Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.
This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.
© 2026 Strategyland by Khurram. All rights reserved.
